Scinai Immunotherapeutics Total Assets Growth & History (SCNI)
Scinai Immunotherapeutics's total assets was $11.6M for fiscal 2025.
View full Scinai Immunotherapeutics company overviewScinai Immunotherapeutics annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $11.6M | −$1.8M | −13.55% |
| 2024 | 2024-12-31 | $13.4M | −$4.0M | −23.03% |
| 2023 | 2023-12-31 | $17.5M | −$9.6M | −35.45% |
| 2022 | 2022-12-31 | $27.1M | −$5.0M | −15.48% |
| 2021 | 2021-12-31 | $32.0M | $14.3M | +80.93% |
| 2020 | 2020-12-31 | $17.7M | — | — |
| 2017 | 2017-12-31 | $23.6M | — | — |
Scinai Immunotherapeutics quarterly total assets
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $17.2M | $5.3M | +45.06% |
| Q1 2026 | 2026-03-31 | $17.6M | — | — |
| Q4 2025 | 2025-12-31 | $11.6M | −$1.8M | −13.55% |
| Q2 2025 | 2025-06-30 | $11.8M | −$3.0M | −20.27% |
| Q4 2024 | 2024-12-31 | $13.4M | −$4.0M | −23.03% |
| Q2 2024 | 2024-06-30 | $14.9M | −$5.0M | −25.36% |
| Q4 2023 | 2023-12-31 | $17.5M | −$9.6M | −35.45% |
| Q2 2023 | 2023-06-30 | $19.9M | −$4.6M | −18.62% |
| Q1 2023 | 2023-03-31 | $23.3M | — | — |
| Q4 2022 | 2022-12-31 | $27.1M | −$5.0M | −15.48% |
| Q2 2022 | 2022-06-30 | $24.4M | — | — |
| Q4 2021 | 2021-12-31 | $32.0M | $14.3M | +80.93% |
| Q3 2021 | 2021-09-30 | $25.1M | — | — |
| Q4 2020 | 2020-12-31 | $17.7M | — | — |
| Q4 2017 | 2017-12-31 | $23.6M | — | — |
Scinai Immunotherapeutics total assets trends
Over the last five fiscal years, Scinai Immunotherapeutics's total assets decreased from $17.7M to $11.6M, a change of −$6.1M. The latest reported quarter, Q2 2026, shows $17.2M.
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Scinai Immunotherapeutics source filings ↗